HomeNDC LookupJ-codes › J9070
J9070

J9070 – Cyclophosphamide, 100 mg · NDC Crosswalk & Billing Units

HCPCS Level II J-code · Medicare Part B drug billing
J-code ● 29 NDCs crosswalked

📋 J9070 summary

J9070 is a HCPCS Level II J-code used to bill Cyclophosphamide, 100 mg. The number of billing units to report depends on the dose administered and the NDC/package billed — use the calculator below.

⚠ An NDC↔HCPCS crosswalk and a published payment limit do not guarantee payer coverage or payment. Always verify the current payer policy and claim format before billing.

🗂️ Key billing facts

HCPCS codeJ9070
DescriptorCyclophosphamide, 100 mg
Billing unitNot available in current dataset
Payment limit / unit Not available in current dataset
Mapped NDCs29
Data periodNot available in current dataset
Last updatedSource date not available

💊 About Cyclophosphamide Injection DRUG GUIDE

Cyclophosphamide Injection is approved to treat a wide range of cancers in both adults and children.

These include malignant lymphomas (such as Hodgkin's disease and Burkitt's lymphoma), multiple myeloma, various leukemias, mycosis fungoides, neuroblastoma, adenocarcinoma of the ovary, retinoblastoma, and breast carcinoma.In pediatric patients only, cyclophosphamide injection is also approved to treat biopsy-proven minimal change nephrotic syndrome (a kidney condition causing protein loss in the urine) when standard steroid therapy has not worked or cannot be tolerated.

It has not been established as safe or effective for nephrotic syndrome in adults or for other kidney diseases.

Read the full Cyclophosphamide Injection drug guide →
Clinical overview from our editorial drug guide for Cyclophosphamide Injection. For billing reference, see the sections above.

🧾 Billing & reimbursement HCPCS · CMS

Medicare payment limit / unit
Est. ASP / unit
Est. after 2% sequester
HCPCS dosage
The CMS payment limit is the Medicare Part B drug allowance (ASP + 6%, statutory). After the 2% federal sequester the effective payment is ≈ ASP + 4.3%; estimated ASP = payment limit ÷ 1.06. Source: CMS Medicare Part B Payment Limit File (quarterly).
Full HCPCS code details (official CMS record)
Long descriptionCyclophosphamide, 100 mg
CoverageD — Special coverage instructions apply
Pricing indicator51 — Drug — priced under the ASP methodology
Type of service1 — Medical care
BETOS-2O1D
ASC payment groupYY
Action codeN — No maintenance this year
Effective date1997-01-01
Date added1984-01-01
Source: CMS HCPCS Level II code file (imported via admin).

🧮 Dosing & billing-units calculator HCPCS UNITS

One billing unit of J9070 = 1 unit. Enter a regimen to convert dose → billing units and project a full course.
Billing units = dose ÷ HCPCS unit size. Most payers require whole units — round per the payer's policy. “Est. Medicare pay” uses the current payment limit. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (JZ when none is discarded) where allowed. Always verify payer-specific rounding before billing.

🔁 NDCs that bill under J9070 CROSSWALKED NDCs

29 NDCs map to J9070. Bill units = how many HCPCS units one package represents.
NDC (11-digit)DrugLabelerPackageStrength Bill units NADAC / unit StatusSource
81298-8114-01 CYCLOPHOSPHAMIDE (SDV) 2 GM Unknown 20 PDAC
81298-8112-01 CYCLOPHOSPHAMIDE (SDV) 1 GM Unknown 10 PDAC
81298-8110-01 CYCLOPHOSPHAMIDE (SDV) 500 MG Unknown 5 PDAC
51407-0748-02 CYCLOPHOSPHAMIDE 200 MG/1 ML Unknown 2 PDAC
51407-0749-05 CYCLOPHOSPHAMIDE 200 MG/1 ML Unknown 2 PDAC
51407-0750-10 CYCLOPHOSPHAMIDE 200 MG/1 ML Unknown 2 PDAC
68001-0565-28 CYCLOPHOSPHAMIDE 200 mg/mL INJECTION, SOLUTION BluePoint 1 VIAL in 1 CARTON (68001-565-28) / 10 mL... 200 mg/mL 2 ● Active PDAC
68001-0564-22 CYCLOPHOSPHAMIDE 200 mg/mL INJECTION, SOLUTION BluePoint 1 VIAL in 1 CARTON (68001-564-22) / 5 mL... 200 mg/mL 2 ● Active PDAC
50742-0521-10 CYCLOPHOSPHAMIDE (MDV) 200 MG/1 ML Unknown 2 PDAC
55150-0270-01 CYCLOPHOSPHAMIDE (SDV,PF,LATEX-FREE) 200 MG/1 ML Unknown 2 PDAC
55150-0271-01 CYCLOPHOSPHAMIDE (SDV,PF,LATEX-FREE) 200 MG/1 ML Unknown 2 PDAC
70860-0218-05 CYCLOPHOSPHAMIDE (MDV,PF,LATEX-FREE) 200 MG/1 ML Unknown 2 PDAC
70860-0218-03 CYCLOPHOSPHAMIDE (MDV,PF,LATEX-FREE) 200 MG/1 ML Unknown 2 PDAC
68001-0442-26 Cyclophosphamide 500 mg/25mL INJECTION, POWDER, FOR SOLUTION BluePoint 1 VIAL, SINGLE-DOSE in 1 CARTON (68001-442... 500 mg/25mL 5 ● Active PDAC
68001-0444-32 Cyclophosphamide 2 g/100mL INJECTION, POWDER, FOR SOLUTION BluePoint 1 VIAL, SINGLE-DOSE in 1 CARTON (68001-444... 2 g/100mL 20 ● Active PDAC
68001-0443-27 Cyclophosphamide 1 g/50mL INJECTION, POWDER, FOR SOLUTION BluePoint 1 VIAL, SINGLE-DOSE in 1 CARTON (68001-443... 1 g/50mL 10 ● Active PDAC
50742-0520-05 CYCLOPHOSPHAMIDE (PF) 200 MG/1 ML Unknown 2 PDAC
50742-0519-02 CYCLOPHOSPHAMIDE (PF) 200 MG/1 ML Unknown 2 PDAC
72603-0104-01 CYCLOPHOSPHAMIDE (SDV,USP,PF) 500 MG Unknown 5 PDAC
72603-0326-01 CYCLOPHOSPHAMIDE (SDV,USP,PF) 1 GM Unknown 10 PDAC
16714-0857-01 Cyclophosphamide 1 g/50mL INJECTION, POWDER, FOR SOLUTION NorthStar 1 VIAL, SINGLE-DOSE in 1 CARTON (16714-857... 1 g/50mL 10 ● Active PDAC
16714-0859-01 Cyclophosphamide 500 mg/25mL INJECTION, POWDER, FOR SOLUTION NorthStar 1 VIAL, SINGLE-DOSE in 1 CARTON (16714-859... 500 mg/25mL 5 ● Active PDAC
16714-0858-01 Cyclophosphamide 2 g/100mL INJECTION, POWDER, FOR SOLUTION NorthStar 1 VIAL, SINGLE-DOSE in 1 CARTON (16714-858... 2 g/100mL 20 ● Active PDAC
68001-0372-32 CYCLOPHOSPHAMIDE (SDV,USP,PF) 2 GM Unknown 20 PDAC
68001-0371-32 CYCLOPHOSPHAMIDE (SDV,USP,PF) 1 GM Unknown 10 PDAC
68001-0370-27 CYCLOPHOSPHAMIDE (SDV,USP,PF) 500 MG Unknown 5 PDAC
70121-1238-01 Cyclophosphamide 500 mg/25mL INJECTION, POWDER, FOR SOLUTION Amneal 1 VIAL, SINGLE-DOSE in 1 CARTON (70121-123... 500 mg/25mL 5 ● Active PDAC
70121-1239-01 Cyclophosphamide 1 g/50mL INJECTION, POWDER, FOR SOLUTION Amneal 1 VIAL, SINGLE-DOSE in 1 CARTON (70121-123... 1 g/50mL 10 ● Active PDAC
70121-1240-01 Cyclophosphamide 2 g/100mL INJECTION, POWDER, FOR SOLUTION Amneal 1 VIAL, SINGLE-DOSE in 1 CARTON (70121-124... 2 g/100mL 20 ● Active PDAC
NDC→HCPCS mappings come from the CMS ASP NDC-HCPCS crosswalk; additional DME MAC / DMEPOS mappings come from PDAC and are labeled separately. NADAC from CMS (weekly). “Status” reflects the product's marketing / obsolete flag in the NDC directory. Presence or absence here does not determine Medicare coverage. Linked NDCs open the full product page.

🗺️ Medicare utilization & spend CMS · PART B

No reportable public Medicare utilization was found for J9070. This is expected for newer codes, low-volume drugs, or codes whose use is billed under another code. CMS also hides any figure covering fewer than 11 patients (a privacy rule), so small-volume use may exist but isn't publishable. Utilization and spend appear here automatically once CMS publishes reportable data for this code.

📊 What bills under J9070

J-codes are billing codes often used for drugs billed under the medical benefit. This connects the billing code to the NDC package records it covers, by ingredient and labeler.

NDC products by ingredient
cyclophosphamide 8
Cyclophosphamide 3
NDC products by labeler
BluePoint Laboratories 5
NorthStar Rx LLC 3
Amneal Pharmaceuticals LLC 3

🗃️ Data sources & freshness

Every figure on this page is computed from public datasets. Here's what each section draws on and how current it is.
HCPCS code & descriptor
CMS HCPCS Level II code file
Loaded
Payment limit & billing unit
CMS Medicare Part B ASP Pricing File (quarterly)
Not available
NDC ↔ HCPCS crosswalk
CMS ASP NDC-HCPCS crosswalk + DMEPDAC (PDAC)
29 NDCs mapped
NADAC acquisition cost
CMS National Average Drug Acquisition Cost (weekly)
Not available for mapped NDCs
Utilization & spend
CMS Part B Spending by Drug · PSPS · Physician & Other Practitioners
No reportable utilization
Figures are estimates for reference and may lag the source files. Always verify against the current CMS files and your payer's policy before submitting claims.

⚠️ Practical billing caveats

  • A crosswalk is not coverage. An NDC mapping or a published payment limit does not guarantee a payer will cover or pay this code. Check the specific plan's policy.
  • Units ≠ milligrams. Bill the number of HCPCS units (dose ÷ the code's unit size), not the milligram dose. Use the calculator above.
  • Discarded drug. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (and JZ when nothing is discarded) where the payer allows.
  • Rounding & partial units. Many payers require whole units; round per the payer's policy, not automatically up.
  • The code can cover more than this drug. Some HCPCS codes span multiple products or strengths — confirm the exact code for the product administered.
  • Figures lag. ASP limits change quarterly and utilization data are released with a delay. Verify against the current CMS files before billing.

J9070 billing FAQ

What is HCPCS code J9070?
J9070 is a HCPCS Level II J-code used to bill Cyclophosphamide, 100 mg under Medicare Part B and most medical (not pharmacy) benefits.
Which NDCs bill under J9070?
29 NDCs currently map to J9070 in the CMS ASP NDC-HCPCS crosswalk. See the NDC crosswalk table above for each product, package, billing units and estimated reimbursement.
Does a crosswalk mean J9070 is covered?
No. An NDC-to-HCPCS crosswalk and a published payment limit do not guarantee coverage or payment. Coverage depends on the payer, the diagnosis and the site of care — always verify the current policy before billing.
For professional billing reference only — verify against the current CMS files before submitting claims.